Changes in Activity of Proline-Specific Peptidases in Rat Model for Dementia of Alzheimer's Type

被引:3
作者
Nazarova, G. A. [1 ]
Kolyasnikova, K. N. [2 ]
Zolotov, N. N. [2 ]
机构
[1] Russian Acad Med Sci, PK Anokhin Inst Normal Physiol, Moscow, Russia
[2] Russian Acad Med Sci, VV Zakusov Inst Pharmacol, Moscow, Russia
关键词
Alzheimer-type dementia; proline-specific peptidases; prolyl endopeptidase; dipeptidyl peptidase IV; enzyme activity; DISEASE; EXPRESSION;
D O I
10.1007/s10517-012-1796-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We studied the role of proline-specifi c peptidases in the pathogenesis of Alzheimer's disease. Testing of conditioned passive avoidance 24 h after learning showed that chronic administration of scopolamine to rats 4-fold reduced the latency of entry into the dark chamber in comparison with controls (intact animals). Activity of prolyl endopeptidase was signifi cantly higher than in the controls in both the cortex and hippocampus. Changes in dipeptidyl peptidase IV activity were observed only in the cortex. Injection of AF-64A toxin into Meynert nucleus basalis reduced the latency of entry into the dark compartment by 75% in comparison with that in sham-operated and intact controls. Prolyl endopeptidase activity was reduced in the frontal cortex and hippocampus, but not in hypothalamus. Changes in dipeptidyl peptidase IV activity were detected only in the frontal cortex.
引用
收藏
页码:674 / 676
页数:3
相关论文
共 14 条
[1]   The expression of TRH, its receptors and degrading enzyme is differentially modulated in the rat limbic system during training in the Morris water maze [J].
Aguilar-Valles, Argel ;
Sanchez, Edith ;
de Gortari, Patricia ;
Garcia-Vazquez, Arlene I. ;
Ramirez-Amaya, Victor ;
Bermudez-Rattoni, Federico ;
Joseph-Bravo, Patricia .
NEUROCHEMISTRY INTERNATIONAL, 2007, 50 (02) :404-417
[2]  
Ashmarin I. P., 2003, ADV FUNCTIONAL NEURO, P85
[3]  
Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/nchem.247, 10.1038/NCHEM.247]
[4]   ALZHEIMER'S DISEASE GENETICS: CURRENT STATUS AND FUTURE PERSPECTIVES [J].
Bertram, Lars .
NEUROBIOLOGY OF DEMENTIA, 2009, 84 :167-184
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
FISHER A, 1986, ANNU REV PHARMACOL, V26, P161
[7]   RAPID RADIOCHEMICAL METHOD FOR DETERMINATION OF CHOLINE-ACETYLTRANSFERASE [J].
FONNUM, F .
JOURNAL OF NEUROCHEMISTRY, 1975, 24 (02) :407-409
[8]   Brain Pharmacokinetics of Two Prolyl Oligopeptidase Inhibitors, JTP-4819 and KYP-2047, in the Rat [J].
Jalkanen, Aaro J. ;
Hakkarainen, Jenni J. ;
Lehtonen, Marko ;
Venalainen, Tetta ;
Kaariainen, Tiina M. ;
Jarho, Elina ;
Suhonen, Marjukka ;
Forsberg, Markus M. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (06) :443-451
[9]   EFFECTS OF BILATERAL CHOLINOTOXIN INFUSIONS ON THE BEHAVIOR AND BRAIN BIOCHEMISTRY OF THE RATS [J].
MANNISTO, PT ;
TUOMAINEN, P ;
KUTEPOVA, O ;
BORISENKO, SA ;
ZOLOTOV, N ;
VORONINA, T .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 49 (01) :33-40
[10]   Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides [J].
Mentlein, R .
REGULATORY PEPTIDES, 1999, 85 (01) :9-24